Press Releases

Novian Health Inc. Announces CE Mark Approval for Novilase® Breast Treatment, a Minimally Invasive Procedure That Uses Laser-Induced Heat for Destruction focal breast tumors up to 2 cm (cm) in size. CE Mark approval allows Novian Health to commercialize its technology in the European Union (EU) and Switzerland, providing women…

CipherHealth, the leading patient engagement software company in patient outreach, is pleased to announce a unique partnership with Medline, a global manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare, to ensure patients have the best possible outcomes and experiences. The partnership will focus on…

Masimo announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers investigated the ability of Masimo ORi™ (Oxygen Reserve Index) to serve as a noninvasive indicator of the arterial partial pressure of oxygen (PaO2) during general anesthesia, to help avoid hyperoxia.1 ORi is…

The International Hospital Federation (IHF) enters into an agreement with CERCA Holdings, Inc. for the latter to serve as networking application for the 43rd annual World Hospital Congress (WHC) to be held in Muscat, Oman on 6 to 9 November, 2019. CERCA is a totally secure mobile networking platform that…

Generex Biotechnology Corporation is pleased to announce that the company has completed the acquisition of Pantheon Medical – Foot & Ankle, a manufacturer of specialty orthopedic surgery products and tools. Under the terms of the deal, Generex will acquire all of the assets of Pantheon Medical including business operations, accounts…

Mercyhealth, a multi-regional healthcare system serving northern Illinois and southern Wisconsin, is partnering with Monarch Medical Technologies to improve care for patients with diabetes or stress-induced hyperglycemia. Using Monarch’s FDA-cleared insulin dosing software, EndoTool®, Mercyhealth will be able to provide their patients precise insulin therapy to safely and rapidly manage…

Biodesix, Inc, the leader in blood-based lung cancer diagnostic solutions, today announced it has entered into an agreement with Thermo Fisher Scientific. The agreement is designed to bring a blood-based next-generation sequencing (NGS) assay to market with premarket approval (PMA) classification from the U.S. Food and Drug Administration (FDA). Biodesix…

BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatment. Early detection of arrhythmia through ICMs enables physician intervention before adverse outcomes occur. Atrial fibrillation (AF), the…

Group 1 Automotive, Inc., an international, Fortune 500 automotive retailer, today announced the expansion of its business presence in the New Mexico market with the acquisition of two BMW/MINI dealerships. The dealerships are located in Albuquerque and Santa Fe, and represent the only BMW and MINI franchises in the state…

Health professionals, educators, and legislative representatives praised four Taiwanese companies for new medical devices aimed at improving the quality of life for patients, decreasing  hospitalization stays, shortening wound healing times and significantly lowering medical costs. Dr. Rudolph Moise, President of Comprehensive Health Center and a Dade County Medical Association Board…